Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2016 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Times Interest Earned came in at -$11.43 in Q1 2026, down 31.47% year-on-year from -$16.67 in Q1 2025, and down 12.03% on a QoQ basis from -$10.2 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of Times Interest Earned data on file, last reported at -$11.43 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 31.47% year-over-year to -$11.43 in Q1 2026; TTM through Mar 2026 was -$9.99, a 16.98% decrease from a year earlier, with the FY2025 full-year figure at -$0.5, up 38.24% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$11.43, down from -$10.2 in the prior quarter.
- Over the last five years, Times Interest Earned for RYTM reached as high as -$7.43 in Q3 2024 and fell as low as -$29.42 in Q1 2024.
- Historically, Times Interest Earned has averaged -$13.0 across 5 years, with a median of -$11.43 in 2026.
- Across the five-year window, Times Interest Earned slumped 71.43% in 2024 and soared 70.46% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$13.98 in 2022, then soared by 35.14% to -$9.07 in 2023, then grew by 16.49% to -$7.57 in 2024, then slumped by 34.64% to -$10.2 in 2025, then slipped by 12.03% to -$11.43 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$11.43 in Q1 2026, -$10.2 in Q4 2025, and -$11.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn | -11.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.43 |
| Dec 31, 2025 | -10.20 |
| Sep 30, 2025 | -11.10 |
| Jun 30, 2025 | -7.79 |
| Mar 31, 2025 | -8.69 |
| Dec 31, 2024 | -7.57 |
| Sep 30, 2024 | -7.43 |
| Jun 30, 2024 | -8.79 |
| Mar 31, 2024 | -29.42 |
| Dec 31, 2023 | -9.07 |
| Sep 30, 2023 | -13.37 |
| Jun 30, 2023 | -14.11 |
| Mar 31, 2023 | -17.16 |
| Dec 31, 2022 | -13.98 |
| Sep 30, 2022 | -14.75 |
| Jun 30, 2022 | -17.35 |
| Mar 31, 2022 | -18.80 |
| Dec 31, 2021 | -17.13 |
| Sep 30, 2021 | -13.79 |
| Jun 30, 2021 | -11.86 |